Trial Profile
A Multicenter,Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects With Epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2024
Price :
$35
*
At a glance
- Drugs Diazepam (Primary)
- Indications Epilepsy; Seizures
- Focus Pharmacokinetics
- Sponsors Aquestive Therapeutics
- 12 Apr 2024 According to an Aquestive Therapeutics media release, the company to present data from this trial at the 76th Annual Meeting of the American Academy of Neurology (AAN) in Denver from April 13 to 18.
- 25 May 2021 Status changed from active, no longer recruiting to completed.
- 24 Jun 2020 Planned End Date changed from 1 May 2020 to 1 Jun 2020.